13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2013-06-30, filed 2013-08-12, with 19 holding rows worth $281,196,000.
- Accession
- 0001085146-13-001357
- Filer
- CIK 1544773
- Filed
- 2013-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2013
A holdings report, 19 entries on the cover page, a total value of $281,196,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $281,196,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SALIX PHARMACEUTICALS INC | 795435106 | COM | 467,943 | $30,954,000 | thousands by filing date | |
| NPS PHARMACEUTICALS INC | 62936P103 | COM | 1,839,263 | $27,791,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 408,166 | $26,865,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 834,798 | $25,678,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 1,331,100 | $23,281,000 | thousands by filing date | |
| FURIEX PHARMACEUTICALS | 36106P101 | COM | 650,608 | $22,166,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 312,858 | $21,503,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 737,186 | $16,402,000 | thousands by filing date | |
| AFFYMETRIX INC | 00826T108 | COM | 3,436,940 | $15,260,000 | thousands by filing date | |
| EMERGENT BIOSOLUTIONS INC | 29089Q105 | COM | 983,669 | $14,185,000 | thousands by filing date | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 622,901 | $13,206,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 1,429,798 | $11,553,000 | thousands by filing date | |
| QUESTCOR PHARMACEUTICALS INC | 74835Y101 | COM | 200,000 | $9,088,000 | thousands by filing date | |
| TARO PHARMACEUTICAL INDS LTD | M8737E108 | SHS | 134,199 | $7,502,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 82,500 | $5,526,000 | thousands by filing date | |
| CHINDEX INTERNATIONAL INC | 169467107 | COM | 334,615 | $5,427,000 | thousands by filing date | |
| LIPOSCIENCE INC | 53630M108 | COM | 422,263 | $2,952,000 | thousands by filing date | |
| SUCAMPO PHARMACEUTICALS-CL A | 864909106 | CL A | 179,988 | $1,184,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 116,000 | $673,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-13-001357 | this filing | 2013-08-12 | acceptance time not in the bulk data set |